277 related articles for article (PubMed ID: 1339417)
21. Precision of genotyping of Epstein-Barr virus by polymerase chain reaction using three gene loci (EBNA-2, EBNA-3C, and EBER): predominance of type A virus associated with Hodgkin's disease.
Lin JC; Lin SC; De BK; Chan WP; Evatt BL; Chan WC
Blood; 1993 Jun; 81(12):3372-81. PubMed ID: 8389616
[TBL] [Abstract][Full Text] [Related]
22. Epstein-Barr viral nuclear antigen 1 antisense oligodeoxynucleotide inhibits proliferation of Epstein-Barr virus-immortalized B cells.
Roth G; Curiel T; Lacy J
Blood; 1994 Jul; 84(2):582-7. PubMed ID: 8025284
[TBL] [Abstract][Full Text] [Related]
23. Synthetic peptides deduced from the amino acid sequence of Epstein-Barr virus nuclear antigen 6 (EBNA 6): antigenic properties, production of monoreactive reagents, and analysis of antibody responses in man.
Falk K; Linde A; Johnson D; Lennette E; Ernberg I; Lundkvist A
J Med Virol; 1995 Aug; 46(4):349-57. PubMed ID: 7595412
[TBL] [Abstract][Full Text] [Related]
24. Interaction between Epstein-Barr virus-determined nuclear antigen (EBNA) and the viral DNA.
Gergely L; Luka J; Klein G
J Gen Virol; 1984 Nov; 65 ( Pt 11)():2043-8. PubMed ID: 6094716
[TBL] [Abstract][Full Text] [Related]
25. The domain of Epstein-Barr virus nuclear antigen 1 essential for binding to oriP region has a sequence fitted for the hypothetical basic-helix-loop-helix structure.
Inoue N; Harada S; Honma T; Kitamura T; Yanagi K
Virology; 1991 May; 182(1):84-93. PubMed ID: 1850915
[TBL] [Abstract][Full Text] [Related]
26. Limited sequence heterogeneity of Epstein-Barr virus nuclear antigen 1 in benign and malignant EBV-associated disorders.
Schuster V; Ott G; Seidenspinner S; Kreth HW
Infection; 2000; 28(3):137-42. PubMed ID: 10879636
[TBL] [Abstract][Full Text] [Related]
27. Domains of the Epstein-Barr virus nuclear antigen 2 (EBNA2) involved in the transactivation of the latent membrane protein 1 and the EBNA Cp promoters.
Sjöblom A; Nerstedt A; Jansson A; Rymo L
J Gen Virol; 1995 Nov; 76 ( Pt 11)():2669-78. PubMed ID: 7595374
[TBL] [Abstract][Full Text] [Related]
28. Induced CD25 expression in a human B-lymphoma cell line transfected with the Epstein-Barr virus nuclear antigen 2 gene.
Harada S; Yanagi K
Microbiol Immunol; 1992; 36(5):479-94. PubMed ID: 1325025
[TBL] [Abstract][Full Text] [Related]
29. The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus.
Ernberg I; Falk K; Minarovits J; Busson P; Tursz T; Masucci MG; Klein G
J Gen Virol; 1989 Nov; 70 ( Pt 11)():2989-3002. PubMed ID: 2479717
[TBL] [Abstract][Full Text] [Related]
30. Second-site homologous recombination in Epstein-Barr virus: insertion of type 1 EBNA 3 genes in place of type 2 has no effect on in vitro infection.
Tomkinson B; Kieff E
J Virol; 1992 Feb; 66(2):780-9. PubMed ID: 1309912
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus nuclear protein 2 is a critical determinant for tumor growth in SCID mice and for transformation in vitro.
Cohen JI; Picchio GR; Mosier DE
J Virol; 1992 Dec; 66(12):7555-9. PubMed ID: 1331538
[TBL] [Abstract][Full Text] [Related]
32. DNA-binding studies of the Epstein-Barr virus nuclear antigen 2 (EBNA-2): evidence for complex formation by latent membrane protein gene promoter-binding proteins in EBNA-2-positive cell lines.
Sauder C; Haiss P; Grässer FA; Zimber-Strobl U; Mueller-Lantzsch N
J Gen Virol; 1994 Nov; 75 ( Pt 11)():3067-79. PubMed ID: 7964616
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr virus with the latent infection nuclear antigen 3B completely deleted is still competent for B-cell growth transformation in vitro.
Chen A; Divisconte M; Jiang X; Quink C; Wang F
J Virol; 2005 Apr; 79(7):4506-9. PubMed ID: 15767450
[TBL] [Abstract][Full Text] [Related]
34. Mutational analysis of the Epstein-Barr virus nuclear antigen 2 by far-Western blotting and DNA-binding studies.
Sauder C; Götzinger N; Schubach WH; Horvath GC; Kremmer E; Krebs A; König S; Zimber Strobl U; Mueller Lantzsch N; Grässer FA
J Gen Virol; 1996 May; 77 ( Pt 5)():991-6. PubMed ID: 8609497
[TBL] [Abstract][Full Text] [Related]
35. The major immunogenic epitopes of Epstein-Barr virus (EBV) nuclear antigen 1 are encoded by sequence domains which vary among nasopharyngeal carcinoma biopsies and EBV-associated cell lines.
Chen MR; Tsai CH; Wu FF; Kan SH; Yang CS; Chen JY
J Gen Virol; 1999 Feb; 80 ( Pt 2)():447-455. PubMed ID: 10073707
[TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr virus nuclear protein 2 transactivates a cis-acting CD23 DNA element.
Wang F; Kikutani H; Tsang SF; Kishimoto T; Kieff E
J Virol; 1991 Aug; 65(8):4101-6. PubMed ID: 1649318
[TBL] [Abstract][Full Text] [Related]
37. Immortalizing genes of Epstein-Barr virus.
Middleton T; Gahn TA; Martin JM; Sugden B
Adv Virus Res; 1991; 40():19-55. PubMed ID: 1659776
[TBL] [Abstract][Full Text] [Related]
38. Interaction of Epstein-Barr viral (EBV) origin of replication (oriP) with EBNA-1 and cellular anti-EBNA-1 proteins.
Wen LT; Lai PK; Bradley G; Tanaka A; Nonoyama M
Virology; 1990 Sep; 178(1):293-6. PubMed ID: 2167556
[TBL] [Abstract][Full Text] [Related]
39. The Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding protein.
Ling PD; Rawlins DR; Hayward SD
Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9237-41. PubMed ID: 8415684
[TBL] [Abstract][Full Text] [Related]
40. The Epstein-Barr virus carrier state: dominance of a single growth-transforming isolate in the blood and in the oropharynx of healthy virus carriers.
Yao QY; Rowe M; Martin B; Young LS; Rickinson AB
J Gen Virol; 1991 Jul; 72 ( Pt 7)():1579-90. PubMed ID: 1649896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
